Rubicon Research Limited IPO
Mainboard₹ 14550 /30 Shares
09 Oct, 2025
Open Date13 Oct, 2025
Close Date14 Oct, 2025
Allotment Date16 Oct, 2025
Listing DateExpected Premium
+ ₹25-30 (5.15%)*Expected Premium provided in this app is derived from market rumors. It is not a guaranteed indicator of the actual listing price and should be interpreted with caution.
Expected Premium
Rubicon Research IPO Issue Details
- Issue Price ₹461-485 per equity share
- Face Value ₹1 Per Equity Share Issue Size
- Total Size 2,84,02,040 shares(aggregating up to ₹1377.5 crore)
- Fresh Share 1,03,09,278 shares(aggregating up to ₹500 crore)
- Offer For Sale 1,80,92,762 shares(aggregating up to ₹877.5 crore)
- Listing at BSE, NSE
- Lead Manager MUFG Intime India Pvt.Ltd.
- Registrar Axis Capital Ltd
IIFL Capital Services Ltd
JM Financial Ltd
SBI Capital Markets Ltd
Market Lot Size
Investors can bid for a minimum of 30 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Retail Investors and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (min) | 1 | 30 | ₹14,550 |
| Retail(max) | 13 | 390 | ₹1,89,150 |
| SHNI(min) | 14 | 420 | ₹2,03,700 |
| SHNI(max) | 68 | 2,040 | ₹9,89,400 |
| BHNI(min) | 69 | 2,070 | ₹10,03,950 |
Rubicon Research IPO Reservation
Rubicon Research IPO offers total NA shares. Out of which NA (NA%) allocated to QIB, NA (NA%) allocated to NII,NA (NA%) allocated to RII, NA (NA%) allocated to employees and NA (NA%) allocated to Anchor investors.
| Investor Category | Shares Offered | Maximum Allottees |
|---|---|---|
| Anchor Investor Shares Offered | NA (NA%) | |
| QIB Shares Offered | NA (NA%) | |
| NII (HNI) Shares Offered | NA (NA%) | |
| bNII < ₹10L | NA (NA%) | |
| sNII < ₹10L | NA (NA%) | |
| Retail Shares Offered | NA (NA%) | |
| Total Shares Offered | NA (NA%) |
Rubicon Research IPO Details
Rubicon Research IPO is a book-built issue of ₹1377.5 crores, The total issue size is ₹1377.5 crores. The IPO of Rubicon Research is priced at ₹461-485 per equity share, which has a face value of ₹1 Per Equity Share each, IPO bidding starts from Oct 9, 2025 and ends on Oct 13, 2025. The allotment for Rubicon Research IPO will be finalized on Oct 14, 2025. Rubicon Research IPO will be listed on BSE, NSE, with a tentative listing date fixed as Oct 16, 2025. The company shall list its equity shares on the BSE, NSE. Axis Capital Ltd
IIFL Capital Services Ltd
JM Financial Ltd
SBI Capital Markets Ltd is the registrar of the issue.
Retail investors can bid for a minimum of 30 shares, extendable to 14,550. S-HNIs will be able to bid for 420 shares at ₹2,03,700, while B-HNIs can also apply for a bid of 2,070 shares at ₹10,03,950. The book-running lead manager for the IPO is/are MUFG Intime India Pvt.Ltd..
The total issue ₹1377.5 crore, comprising a fresh issue of 1,03,09,278 shares ₹500 crore and having Offer for Sale (OFS) of 1,80,92,762 shares to mop up ₹877.5 crore.
The Rubicon Research IPO sets its price band at 461-485 for each share. A single application for Rubicon Research Limited IPO must contain at least 30 shares. Sentiment investors need to invest a minimum of 30 through their retail account. For investors to prevent oversubscription issues, they should submit bids at the cutoff price, which estimates about ₹14,550 In order to participate in the sNII, investors must purchase at least 14 lots of 420 shares for ₹2,03,700, while the bNII requires 69 lots of 2,070 shares for an investment of ₹10,03,950.
Rubicon Research Valuations
Rubicon Research Company Financials
| 30-Jun-25 | 31-Mar-25 | 31-Mar-24 | 31-Mar-23 | |
|---|---|---|---|---|
| Assets | 1647.60 | 1451.43 | 1109.49 | 749.70 |
| Revenue | 356.95 | 1296.22 | 872.39 | 419.00 |
| Profit After Tax | 43.30 | 134.36 | 91.01 | -16.89 |
| Net Worth | 593.67 | 540.98 | 385.00 | 286.38 |
| Reserves & Surplus | 593.67 | 540.98 | 385.00 | 286.38 |
| Total Borrowing | 495.78 | 393.17 | 396.41 | 317.91 |
About Rubicon Research Company
Founded in 1999, Rubicon Research Limited is a pharmaceutical organization that deals with the development, manufacturing, and marketing of differentiated formulation.
As of March 31, 2024, Rubicon Research Limited had an approved portfolio of 69 active Abbreviated New Drug Application (ANDA) and New Drug Application (NDA) products of the US FDA. The portfolio comprises 55 commercialized products of which the US generic pharmaceutical market size is USD 2,386.6 million and which has contributed USD 154.3 million by Rubicon Research Limited during Fiscal 2024.
Rubicon Research - Promoter(s)
General Atlantic Singapore RR Pte. Ltd., Pratibha Pilgaonkar, Sudhir Dhirendra Pilgaonkar, Parag Suganchand Sancheti, Surabhi Parag Sancheti and Sumant Sudhir Pilgaonkar
Pre Issue Share Holding : N/A%
Post Issue Share Holding : N/A%
Rubicon Research IPO - Issue Objectives
Prepayment or scheduled repayment of all or a portion of certain outstanding borrowings availed by the Company
Funding inorganic growth through unidentified acquisitions and other strategic initiatives and General corporate purposes
Contact Details
Rubicon Research
MedOne House, B-75, Road No. 33, Wagle Estate, Thane West-400604, Maharashtra, India Thane, Maharashtra, 400604
022 61414000
Registrar Contact Details
MUFG Intime India Private Limited (Link Intime)
+91-22-4918 6270
Rubicon Research IPO - FAQs
Ans. Rubicon Research Limited IPO is a Mainboard IPO. The issue is priced at ₹461-485 per equity share. The minimum order quantity is 30 Shares. The IPO opens on Oct 9, 2025, and closes on Oct 13, 2025. Axis Capital Ltd IIFL Capital Services Ltd JM Financial Ltd SBI Capital Markets Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
Ans. The Rubicon Research Limited IPO opens on Oct 9, 2025 and closes on Oct 13, 2025.
Ans. You can track the real-time subscription numbers using the links below:
Ans. The size of Rubicon Research Limited IPO is Total 1,377.50 Cr : #Fresh Issue : 1,03,09,278 shares(aggregating up to ₹500.00 Cr) + #OFS : 1,80,92,762 shares of ₹1(aggregating up to ₹877.50 Cr).
Ans. The IPO price band is set between ₹461-485 per equity share.
Ans. To apply for Rubicon Research Limited IPO IPO, follow the steps given below:
- - Open the IPO Ji App or Website
- - Find Rubicon Research Limited IPO in the List of IPOs
- - Press Apply Button
- - Select Your Demat Account
- - Select Your Shares Quantity and Submit
- - Track Your IPO Status
Ans. The share allotment date of Rubicon Research Limited IPO is Oct 14, 2025.
Ans. The Rubicon Research Limited IPO will be listed on Oct 16, 2025.
Ans. Follow the steps to check the allotment status for Rubicon Research Limited IPO here.
